Compile Data Set for Download or QSAR
Report error Found 194 Enz. Inhib. hit(s) with all data for entry = 13261
TargetUbiquitin carboxyl-terminal hydrolase 1/WD repeat-containing protein 48(Human)
Jiangsu Yahong Meditech Co.

US Patent
LigandPNGBDBM772007(2-(4-Chloro-1-isopropyl-1H-pyrazol- 5-yl)-N-(4-(1-...)
Affinity DataIC50: 0.450nMAssay Description:Experimental Methods1) Preparation of 1× assay buffer: 1× assay buffer (modified Tris buffer) was prepared;2) Compound dilution: The compound was tra...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/2/2026
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1/WD repeat-containing protein 48(Human)
Jiangsu Yahong Meditech Co.

US Patent
LigandPNGBDBM771925(5-Ethynyl-2-(2-isopropylphenyl)-N- (4-(1-methyl-4-...)
Affinity DataIC50: 0.470nMAssay Description:Experimental Methods1) Preparation of 1× assay buffer: 1× assay buffer (modified Tris buffer) was prepared;2) Compound dilution: The compound was tra...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/2/2026
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1/WD repeat-containing protein 48(Human)
Jiangsu Yahong Meditech Co.

US Patent
LigandPNGBDBM772009(2-(2-Cyclopropylphenyl)-5- methoxy-N-(4-(1-methyl-...)
Affinity DataIC50: 0.800nMAssay Description:Experimental Methods1) Preparation of 1× assay buffer: 1× assay buffer (modified Tris buffer) was prepared;2) Compound dilution: The compound was tra...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/2/2026
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1/WD repeat-containing protein 48(Human)
Jiangsu Yahong Meditech Co.

US Patent
LigandPNGBDBM772013(2-(2-Cyclopropylphenyl)-N-(4-(1- methyl-4-(trifluo...)
Affinity DataIC50: 1nMAssay Description:Experimental Methods1) Preparation of 1× assay buffer: 1× assay buffer (modified Tris buffer) was prepared;2) Compound dilution: The compound was tra...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/2/2026
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1/WD repeat-containing protein 48(Human)
Jiangsu Yahong Meditech Co.

US Patent
LigandPNGBDBM772004(2-(4-Chloro-1-isopropyl-1H-pyrazol- 5-yl)-5-methox...)
Affinity DataIC50: 1.10nMAssay Description:Experimental Methods1) Preparation of 1× assay buffer: 1× assay buffer (modified Tris buffer) was prepared;2) Compound dilution: The compound was tra...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/2/2026
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1/WD repeat-containing protein 48(Human)
Jiangsu Yahong Meditech Co.

US Patent
LigandPNGBDBM771895(US20250289799, Example 38)
Affinity DataIC50: 1.10nMAssay Description:Experimental Methods1) Preparation of 1× assay buffer: 1× assay buffer (modified Tris buffer) was prepared;2) Compound dilution: The compound was tra...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/2/2026
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1/WD repeat-containing protein 48(Human)
Jiangsu Yahong Meditech Co.

US Patent
LigandPNGBDBM771926(5-(Difluoromethoxy)-2-(2- isopropylphenyl)-N-(4-(1...)
Affinity DataIC50: 1.10nMAssay Description:Experimental Methods1) Preparation of 1× assay buffer: 1× assay buffer (modified Tris buffer) was prepared;2) Compound dilution: The compound was tra...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/2/2026
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1/WD repeat-containing protein 48(Human)
Jiangsu Yahong Meditech Co.

US Patent
LigandPNGBDBM771863(US20250289799, Example 4)
Affinity DataIC50: 1.20nMAssay Description:Experimental Methods1) Preparation of 1× assay buffer: 1× assay buffer (modified Tris buffer) was prepared;2) Compound dilution: The compound was tra...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/2/2026
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1/WD repeat-containing protein 48(Human)
Jiangsu Yahong Meditech Co.

US Patent
LigandPNGBDBM771890(US20250289799, Example 33)
Affinity DataIC50: 1.20nMAssay Description:Experimental Methods1) Preparation of 1× assay buffer: 1× assay buffer (modified Tris buffer) was prepared;2) Compound dilution: The compound was tra...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/2/2026
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1/WD repeat-containing protein 48(Human)
Jiangsu Yahong Meditech Co.

US Patent
LigandPNGBDBM771865(US20250289799, Example 6)
Affinity DataIC50: 1.20nMAssay Description:Experimental Methods1) Preparation of 1× assay buffer: 1× assay buffer (modified Tris buffer) was prepared;2) Compound dilution: The compound was tra...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/2/2026
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1/WD repeat-containing protein 48(Human)
Jiangsu Yahong Meditech Co.

US Patent
LigandPNGBDBM772008(2-(4-Chloro-1-isopropyl-1H-pyrazol- 5-yl)-N-(4-(5-...)
Affinity DataIC50: 1.20nMAssay Description:Experimental Methods1) Preparation of 1× assay buffer: 1× assay buffer (modified Tris buffer) was prepared;2) Compound dilution: The compound was tra...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/2/2026
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1/WD repeat-containing protein 48(Human)
Jiangsu Yahong Meditech Co.

US Patent
LigandPNGBDBM771931(Methyl 2-(2-(2-isopropylphenyl)-4- ((4-(1-methyl-4...)
Affinity DataIC50: 1.30nMAssay Description:Experimental Methods1) Preparation of 1× assay buffer: 1× assay buffer (modified Tris buffer) was prepared;2) Compound dilution: The compound was tra...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/2/2026
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1/WD repeat-containing protein 48(Human)
Jiangsu Yahong Meditech Co.

US Patent
LigandPNGBDBM772005(2-(4-Chloro-1-isopropyl-1H-pyrazol- 5-yl)-5-methox...)
Affinity DataIC50: 1.40nMAssay Description:Experimental Methods1) Preparation of 1× assay buffer: 1× assay buffer (modified Tris buffer) was prepared;2) Compound dilution: The compound was tra...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/2/2026
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1/WD repeat-containing protein 48(Human)
Jiangsu Yahong Meditech Co.

US Patent
LigandPNGBDBM772053(US20250289799, Example 216)
Affinity DataIC50: 1.40nMAssay Description:Experimental Methods1) Preparation of 1× assay buffer: 1× assay buffer (modified Tris buffer) was prepared;2) Compound dilution: The compound was tra...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/2/2026
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1/WD repeat-containing protein 48(Human)
Jiangsu Yahong Meditech Co.

US Patent
LigandPNGBDBM771867(US20250289799, Example 8)
Affinity DataIC50: 1.40nMAssay Description:Experimental Methods1) Preparation of 1× assay buffer: 1× assay buffer (modified Tris buffer) was prepared;2) Compound dilution: The compound was tra...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/2/2026
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1/WD repeat-containing protein 48(Human)
Jiangsu Yahong Meditech Co.

US Patent
LigandPNGBDBM772043(5-Ethynyl-2-(1-isopropyl-4-methyl- 1H-pyrazol-5-yl...)
Affinity DataIC50: 1.40nMAssay Description:Experimental Methods1) Preparation of 1× assay buffer: 1× assay buffer (modified Tris buffer) was prepared;2) Compound dilution: The compound was tra...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/2/2026
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1/WD repeat-containing protein 48(Human)
Jiangsu Yahong Meditech Co.

US Patent
LigandPNGBDBM771933(4'-Cyclopropyl-N-(4-(1-isopropyl-4- (trifluorometh...)
Affinity DataIC50: 1.5nMAssay Description:Experimental Methods1) Preparation of 1× assay buffer: 1× assay buffer (modified Tris buffer) was prepared;2) Compound dilution: The compound was tra...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/2/2026
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1/WD repeat-containing protein 48(Human)
Jiangsu Yahong Meditech Co.

US Patent
LigandPNGBDBM772048(US20250289799, Example 209)
Affinity DataIC50: 1.60nMAssay Description:Experimental Methods1) Preparation of 1× assay buffer: 1× assay buffer (modified Tris buffer) was prepared;2) Compound dilution: The compound was tra...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/2/2026
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1/WD repeat-containing protein 48(Human)
Jiangsu Yahong Meditech Co.

US Patent
LigandPNGBDBM771922(2-(2-Isopropylphenyl)-N-(3- methoxy-4-(1-methyl-4-...)
Affinity DataIC50: 1.70nMAssay Description:Experimental Methods1) Preparation of 1× assay buffer: 1× assay buffer (modified Tris buffer) was prepared;2) Compound dilution: The compound was tra...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/2/2026
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1/WD repeat-containing protein 48(Human)
Jiangsu Yahong Meditech Co.

US Patent
LigandPNGBDBM771999(2-(2-(Dimethylamino)phenyl)-5- methoxy-N-(4-(1-met...)
Affinity DataIC50: 1.70nMAssay Description:Experimental Methods1) Preparation of 1× assay buffer: 1× assay buffer (modified Tris buffer) was prepared;2) Compound dilution: The compound was tra...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/2/2026
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1/WD repeat-containing protein 48(Human)
Jiangsu Yahong Meditech Co.

US Patent
LigandPNGBDBM771871(US20250289799, Example 13)
Affinity DataIC50: 1.90nMAssay Description:Experimental Methods1) Preparation of 1× assay buffer: 1× assay buffer (modified Tris buffer) was prepared;2) Compound dilution: The compound was tra...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/2/2026
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1/WD repeat-containing protein 48(Human)
Jiangsu Yahong Meditech Co.

US Patent
LigandPNGBDBM771905(2-(2-Isopropylphenyl)-5-methoxy-N- ((1-(1-methyl-4...)
Affinity DataIC50: 2.10nMAssay Description:Experimental Methods1) Preparation of 1× assay buffer: 1× assay buffer (modified Tris buffer) was prepared;2) Compound dilution: The compound was tra...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/2/2026
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1/WD repeat-containing protein 48(Human)
Jiangsu Yahong Meditech Co.

US Patent
LigandPNGBDBM772006(2-(4-Chloro-1-isopropyl-1H-pyrazol- 5-yl)-N-(4-(py...)
Affinity DataIC50: 2.10nMAssay Description:Experimental Methods1) Preparation of 1× assay buffer: 1× assay buffer (modified Tris buffer) was prepared;2) Compound dilution: The compound was tra...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/2/2026
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1/WD repeat-containing protein 48(Human)
Jiangsu Yahong Meditech Co.

US Patent
LigandPNGBDBM771902(2-(2-Isopropylphenyl)-5-methoxy-N- methyl-N-((1-(1...)
Affinity DataIC50: 2.10nMAssay Description:Experimental Methods1) Preparation of 1× assay buffer: 1× assay buffer (modified Tris buffer) was prepared;2) Compound dilution: The compound was tra...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/2/2026
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1/WD repeat-containing protein 48(Human)
Jiangsu Yahong Meditech Co.

US Patent
LigandPNGBDBM771998(2-(2-Isopropylpyridin-3-yl)-5- methoxy-N-(4-(5-met...)
Affinity DataIC50: 2.10nMAssay Description:Experimental Methods1) Preparation of 1× assay buffer: 1× assay buffer (modified Tris buffer) was prepared;2) Compound dilution: The compound was tra...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/2/2026
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1/WD repeat-containing protein 48(Human)
Jiangsu Yahong Meditech Co.

US Patent
LigandPNGBDBM772052(US20250289799, Example 215)
Affinity DataIC50: 2.20nMAssay Description:Experimental Methods1) Preparation of 1× assay buffer: 1× assay buffer (modified Tris buffer) was prepared;2) Compound dilution: The compound was tra...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/2/2026
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1/WD repeat-containing protein 48(Human)
Jiangsu Yahong Meditech Co.

US Patent
LigandPNGBDBM771996(2-(2-Cyclopropylpyridin-3-yl)-5- (difluoromethoxy)...)
Affinity DataIC50: 2.20nMAssay Description:Experimental Methods1) Preparation of 1× assay buffer: 1× assay buffer (modified Tris buffer) was prepared;2) Compound dilution: The compound was tra...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/2/2026
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1/WD repeat-containing protein 48(Human)
Jiangsu Yahong Meditech Co.

US Patent
LigandPNGBDBM772003(2-(4-Chloro-1-isopropyl-1H-pyrazol- 5-yl)-5-methox...)
Affinity DataIC50: 2.30nMAssay Description:Experimental Methods1) Preparation of 1× assay buffer: 1× assay buffer (modified Tris buffer) was prepared;2) Compound dilution: The compound was tra...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/2/2026
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1/WD repeat-containing protein 48(Human)
Jiangsu Yahong Meditech Co.

US Patent
LigandPNGBDBM771897(US20250289799, Example 40)
Affinity DataIC50: 2.30nMAssay Description:Experimental Methods1) Preparation of 1× assay buffer: 1× assay buffer (modified Tris buffer) was prepared;2) Compound dilution: The compound was tra...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/2/2026
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1/WD repeat-containing protein 48(Human)
Jiangsu Yahong Meditech Co.

US Patent
LigandPNGBDBM772011(2-(2-Cyclopropylphenyl)-5- methoxy-N-(2-methoxy-4-...)
Affinity DataIC50: 2.30nMAssay Description:Experimental Methods1) Preparation of 1× assay buffer: 1× assay buffer (modified Tris buffer) was prepared;2) Compound dilution: The compound was tra...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/2/2026
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1/WD repeat-containing protein 48(Human)
Jiangsu Yahong Meditech Co.

US Patent
LigandPNGBDBM771968(4'-Cyclopropyl-N-(4-(1-cyclopropyl- 4-(trifluorome...)
Affinity DataIC50: 2.60nMAssay Description:Experimental Methods1) Preparation of 1× assay buffer: 1× assay buffer (modified Tris buffer) was prepared;2) Compound dilution: The compound was tra...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/2/2026
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1/WD repeat-containing protein 48(Human)
Jiangsu Yahong Meditech Co.

US Patent
LigandPNGBDBM771889(US20250289799, Example 32)
Affinity DataIC50: 2.80nMAssay Description:Experimental Methods1) Preparation of 1× assay buffer: 1× assay buffer (modified Tris buffer) was prepared;2) Compound dilution: The compound was tra...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/2/2026
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1/WD repeat-containing protein 48(Human)
Jiangsu Yahong Meditech Co.

US Patent
LigandPNGBDBM771896(US20250289799, Example 39)
Affinity DataIC50: 2.80nMAssay Description:Experimental Methods1) Preparation of 1× assay buffer: 1× assay buffer (modified Tris buffer) was prepared;2) Compound dilution: The compound was tra...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/2/2026
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1/WD repeat-containing protein 48(Human)
Jiangsu Yahong Meditech Co.

US Patent
LigandPNGBDBM772040(2-(1-Isopropyl-4-methyl-1H- pyrazol-5-yl)-5-methox...)
Affinity DataIC50: 2.80nMAssay Description:Experimental Methods1) Preparation of 1× assay buffer: 1× assay buffer (modified Tris buffer) was prepared;2) Compound dilution: The compound was tra...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/2/2026
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1/WD repeat-containing protein 48(Human)
Jiangsu Yahong Meditech Co.

US Patent
LigandPNGBDBM771862(US20250289799, Example 3)
Affinity DataIC50: 2.80nMAssay Description:Experimental Methods1) Preparation of 1× assay buffer: 1× assay buffer (modified Tris buffer) was prepared;2) Compound dilution: The compound was tra...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/2/2026
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1/WD repeat-containing protein 48(Human)
Jiangsu Yahong Meditech Co.

US Patent
LigandPNGBDBM771946(4'-Cyclopropyl-N-(4-(1-isopropyl-4- (trifluorometh...)
Affinity DataIC50: 2.90nMAssay Description:Experimental Methods1) Preparation of 1× assay buffer: 1× assay buffer (modified Tris buffer) was prepared;2) Compound dilution: The compound was tra...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/2/2026
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1/WD repeat-containing protein 48(Human)
Jiangsu Yahong Meditech Co.

US Patent
LigandPNGBDBM772010(2-(2-Cyclopropylphenyl)-5- methoxy-N-(4-(5-methyl-...)
Affinity DataIC50: 2.90nMAssay Description:Experimental Methods1) Preparation of 1× assay buffer: 1× assay buffer (modified Tris buffer) was prepared;2) Compound dilution: The compound was tra...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/2/2026
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1/WD repeat-containing protein 48(Human)
Jiangsu Yahong Meditech Co.

US Patent
LigandPNGBDBM771997(2-(2-Isopropylpyridin-3-yl)-5- methoxy-N-(4-(1-met...)
Affinity DataIC50: 2.90nMAssay Description:Experimental Methods1) Preparation of 1× assay buffer: 1× assay buffer (modified Tris buffer) was prepared;2) Compound dilution: The compound was tra...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/2/2026
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1/WD repeat-containing protein 48(Human)
Jiangsu Yahong Meditech Co.

US Patent
LigandPNGBDBM772042(2-(1-Isopropyl-4-methyl-1H- pyrazol-5-yl)-5-methox...)
Affinity DataIC50: 3nMAssay Description:Experimental Methods1) Preparation of 1× assay buffer: 1× assay buffer (modified Tris buffer) was prepared;2) Compound dilution: The compound was tra...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/2/2026
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1/WD repeat-containing protein 48(Human)
Jiangsu Yahong Meditech Co.

US Patent
LigandPNGBDBM771965(5-Chloro-4'-cyclopropyl-N-(4-(1- cyclopropyl-4-(tr...)
Affinity DataIC50: 3.10nMAssay Description:Experimental Methods1) Preparation of 1× assay buffer: 1× assay buffer (modified Tris buffer) was prepared;2) Compound dilution: The compound was tra...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/2/2026
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1/WD repeat-containing protein 48(Human)
Jiangsu Yahong Meditech Co.

US Patent
LigandPNGBDBM771908(N-(4-(2-Ethoxyethoxy)benzyl)-2-(2- isopropylphenyl...)
Affinity DataIC50: 3.20nMAssay Description:Experimental Methods1) Preparation of 1× assay buffer: 1× assay buffer (modified Tris buffer) was prepared;2) Compound dilution: The compound was tra...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/2/2026
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1/WD repeat-containing protein 48(Human)
Jiangsu Yahong Meditech Co.

US Patent
LigandPNGBDBM771975(4'-Cyclopropyl-5-(difluoromethoxy)- 6'-methoxy-N-(...)
Affinity DataIC50: 3.20nMAssay Description:Experimental Methods1) Preparation of 1× assay buffer: 1× assay buffer (modified Tris buffer) was prepared;2) Compound dilution: The compound was tra...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/2/2026
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1/WD repeat-containing protein 48(Human)
Jiangsu Yahong Meditech Co.

US Patent
LigandPNGBDBM771974(4'-Cyclopropyl-5-(difluoromethoxy)- 6'-methoxy-N-(...)
Affinity DataIC50: 3.20nMAssay Description:Experimental Methods1) Preparation of 1× assay buffer: 1× assay buffer (modified Tris buffer) was prepared;2) Compound dilution: The compound was tra...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/2/2026
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1/WD repeat-containing protein 48(Human)
Jiangsu Yahong Meditech Co.

US Patent
LigandPNGBDBM772038(2-(1-Cyclopropyl-4-methyl-1H- pyrazol-5-yl)-5-meth...)
Affinity DataIC50: 3.20nMAssay Description:Experimental Methods1) Preparation of 1× assay buffer: 1× assay buffer (modified Tris buffer) was prepared;2) Compound dilution: The compound was tra...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/2/2026
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1/WD repeat-containing protein 48(Human)
Jiangsu Yahong Meditech Co.

US Patent
LigandPNGBDBM771932(4'-Cyclopropyl-5,6'-dimethoxy-N- methyl-N-((1-(1-m...)
Affinity DataIC50: 3.30nMAssay Description:Experimental Methods1) Preparation of 1× assay buffer: 1× assay buffer (modified Tris buffer) was prepared;2) Compound dilution: The compound was tra...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/2/2026
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1/WD repeat-containing protein 48(Human)
Jiangsu Yahong Meditech Co.

US Patent
LigandPNGBDBM771903(2-(2-Isopropylphenyl)-5-methoxy-N- ((4-(pyridin-2-...)
Affinity DataIC50: 3.30nMAssay Description:Experimental Methods1) Preparation of 1× assay buffer: 1× assay buffer (modified Tris buffer) was prepared;2) Compound dilution: The compound was tra...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/2/2026
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1/WD repeat-containing protein 48(Human)
Jiangsu Yahong Meditech Co.

US Patent
LigandPNGBDBM771993(2-(2-Cyclopropylpyridin-3-yl)-5- methoxy-N-(4-(1-m...)
Affinity DataIC50: 3.40nMAssay Description:Experimental Methods1) Preparation of 1× assay buffer: 1× assay buffer (modified Tris buffer) was prepared;2) Compound dilution: The compound was tra...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/2/2026
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1/WD repeat-containing protein 48(Human)
Jiangsu Yahong Meditech Co.

US Patent
LigandPNGBDBM772047(US20250289799, Example 207)
Affinity DataIC50: 3.5nMAssay Description:Experimental Methods1) Preparation of 1× assay buffer: 1× assay buffer (modified Tris buffer) was prepared;2) Compound dilution: The compound was tra...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/2/2026
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1/WD repeat-containing protein 48(Human)
Jiangsu Yahong Meditech Co.

US Patent
LigandPNGBDBM772046(US20250289799, Example 206)
Affinity DataIC50: 3.5nMAssay Description:Experimental Methods1) Preparation of 1× assay buffer: 1× assay buffer (modified Tris buffer) was prepared;2) Compound dilution: The compound was tra...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/2/2026
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1/WD repeat-containing protein 48(Human)
Jiangsu Yahong Meditech Co.

US Patent
LigandPNGBDBM772000(2-(2-(Dimethylamino)phenyl)-5- methoxy-N-(4-(5-met...)
Affinity DataIC50: 3.60nMAssay Description:Experimental Methods1) Preparation of 1× assay buffer: 1× assay buffer (modified Tris buffer) was prepared;2) Compound dilution: The compound was tra...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
1/2/2026
Entry Details
US Patent

Displayed 1 to 50 (of 194 total ) | Next | Last >>
Jump to: